Stephanie DerOhannessian

1.8k total citations
15 papers, 438 citations indexed

About

Stephanie DerOhannessian is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, Stephanie DerOhannessian has authored 15 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Immunology. Recurrent topics in Stephanie DerOhannessian's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipid metabolism and disorders (5 papers) and Genetic Associations and Epidemiology (4 papers). Stephanie DerOhannessian is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipid metabolism and disorders (5 papers) and Genetic Associations and Epidemiology (4 papers). Stephanie DerOhannessian collaborates with scholars based in United States, Germany and Canada. Stephanie DerOhannessian's co-authors include Daniel J. Rader, Muredach P. Reilly, Mingyao Li, Nehal N. Mehta, Serkalem Demissie, Robert A. Hegele, Sekar Kathiresan, Andrew C. Edmondson, Sumeet A. Khetarpal and Megan L. Wolfe and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

Stephanie DerOhannessian

15 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie DerOhannessian United States 11 144 136 130 122 104 15 438
Antoine Rimbert France 12 212 1.5× 112 0.8× 74 0.6× 114 0.9× 42 0.4× 43 457
Jeroen A. Sierts Netherlands 6 199 1.4× 181 1.3× 196 1.5× 125 1.0× 32 0.3× 9 446
Alinda W.M. Schimmel Netherlands 13 228 1.6× 161 1.2× 189 1.5× 131 1.1× 33 0.3× 20 491
Stela Z. Berisha United States 8 147 1.0× 41 0.3× 86 0.7× 104 0.9× 77 0.7× 11 342
Mark Burgert United States 6 152 1.1× 71 0.5× 42 0.3× 168 1.4× 88 0.8× 11 445
Josefina Naya-Vigne United States 11 228 1.6× 81 0.6× 209 1.6× 177 1.5× 51 0.5× 12 554
Jolanta Krauze Poland 11 89 0.6× 106 0.8× 42 0.3× 73 0.6× 60 0.6× 43 323
T Okura Japan 9 62 0.4× 158 1.2× 83 0.6× 262 2.1× 73 0.7× 22 515
Pascalle S. Monraats Netherlands 11 167 1.2× 152 1.1× 37 0.3× 78 0.6× 84 0.8× 15 382
Daniel Mar United States 11 69 0.5× 51 0.4× 71 0.5× 280 2.3× 80 0.8× 17 493

Countries citing papers authored by Stephanie DerOhannessian

Since Specialization
Citations

This map shows the geographic impact of Stephanie DerOhannessian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie DerOhannessian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie DerOhannessian more than expected).

Fields of papers citing papers by Stephanie DerOhannessian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie DerOhannessian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie DerOhannessian. The network helps show where Stephanie DerOhannessian may publish in the future.

Co-authorship network of co-authors of Stephanie DerOhannessian

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie DerOhannessian. A scholar is included among the top collaborators of Stephanie DerOhannessian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie DerOhannessian. Stephanie DerOhannessian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gouma, Sigrid, Madison E. Weirick, Marcus J. Bolton, et al.. (2021). Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration. JCI Insight. 6(16). 11 indexed citations
2.
Tuteja, Sony, Liming Qu, Marijana Vujković, et al.. (2018). Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin. Journal of the American Heart Association. 7(19). e03488–e03488. 11 indexed citations
3.
4.
Tuteja, Sony, Lu Wang, Richard L. Dunbar, et al.. (2017). Genetic coding variants in the niacin receptor, hydroxyl–carboxylic acid receptor 2, and response to niacin therapy. Pharmacogenetics and Genomics. 27(8). 285–293. 9 indexed citations
5.
Ueda, Masako, Richard L. Dunbar, Anna Wolska, et al.. (2017). A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis. The Journal of Clinical Endocrinology & Metabolism. 102(5). 1454–1457. 37 indexed citations
6.
Ferguson, Jane F., Nuala J. Meyer, Liming Qu, et al.. (2014). Integrative genomics identifies 7p11.2 as a novel locus for fever and clinical stress response in humans. Human Molecular Genetics. 24(6). 1801–1812. 15 indexed citations
8.
Krishnamoorthy, Parasuram, Stephanie DerOhannessian, Daniel J. Rader, et al.. (2013). Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors. Clinical and Experimental Dermatology. 39(1). 19–24. 37 indexed citations
9.
Li, Ruxue, Parasuram Krishnamoorthy, Yong Yu, et al.. (2012). Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors. 15th International & 14th European Congress of Endocrinology. 29. 2 indexed citations
10.
Ferguson, Jane F., Christine Hinkle, Nehal N. Mehta, et al.. (2012). Translational Studies of Lipoprotein-Associated Phospholipase A2 in Inflammation and Atherosclerosis. Journal of the American College of Cardiology. 59(8). 764–772. 39 indexed citations
11.
Yu, Yiding, Parasuram Krishnamoorthy, Babak Saboury, et al.. (2012). Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study.. PubMed. 2(4). 285–92. 29 indexed citations
12.
Mehta, Nehal N., Mingyao Li, Dilusha A. William, et al.. (2011). The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels. European Heart Journal. 32(8). 963–971. 55 indexed citations
13.
Khetarpal, Sumeet A., Andrew C. Edmondson, Avanthi Raghavan, et al.. (2011). Mining the LIPG Allelic Spectrum Reveals the Contribution of Rare and Common Regulatory Variants to HDL Cholesterol. PLoS Genetics. 7(12). e1002393–e1002393. 26 indexed citations
14.
Qasim, Atif, Liming Qu, Rajesh Movva, et al.. (2010). ASSOCIATION OF GENOME WIDE LOCI FOR CAD WITH DISTRIBUTION OF CORONARY DISEASE. Journal of the American College of Cardiology. 55(10). A124.E1161–A124.E1161. 2 indexed citations
15.
Edmondson, Andrew C., Robert Brown, Sekar Kathiresan, et al.. (2009). Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. Journal of Clinical Investigation. 119(4). 1042–50. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026